---
figid: PMC6676405__ol-18-03-3399-g01
figlink: /pmc/articles/PMC6676405/figure/f2-ol-0-0-10626/
number: F2
caption: Putative Cripto-1 targets the MAPK, FA and ErbB signalling pathways. Solid
  arrows and boxes represent the data observed in U87-Cr1 cells confirmed from the
  literature, while dotted arrows and boxes represent data based on Kyoto Encyclopedia
  of Genes and Genomes pathway analysis but it is not known if Cripto-1 signals through
  these cascades or directly regulate these putative targets. Cripto-1 phosphorylates
  EGFR (Ser1070) or FGFR1 (Tyr654) which may be a part of the MAPK signalling pathway
  mediating cellular proliferation. In the FA pathway, Cripto-1 may regulate cell
  motility and invasion through binding ITGA, mediating the activation of the Src
  signalling cascade (Tyr418), FAK (Tyr396) and PXN (Tyr118). In addition, Cripto-1
  may signal, through the same binding, to control cellular survival through Src (Tyr418),
  FAK (Tyr396), p130CAS (Tyr410) and Bcl2 (Thr69) or to regulate cellular proliferation
  through Src (Tyr418), FAK (Tyr396), p130CAS (Tyr410) c-Jun (Ser63). This representative
  figure shows that Cripto-1 may signal through the ErbB signalling pathway to control
  cell migration, invasion and adhesion or angiogenesis via the signalling cascade
  ErbB1 (EFGR)(Ser1070)/ErbB2 (Her2)(Tyr877), Src (Tyr418), and FAK (Tyr396) or ErbB1
  (EFGR)(Ser1070)/ErbB2 (Her2)(Tyr877), c-Jun (Ser63), respectively. MAPK, mitogen-activated
  protein kinase; FA, focal adhesion; EGFR, epithelial growth factor receptor; FGFR,
  fibroblast growth factor receptor; ITGA, integrin a subunit; FAK, focal adhesion
  kinase; PXN, Paxillin.
pmcid: PMC6676405
papertitle: Cripto-1 overexpression in U87 glioblastoma cells activates MAPK, focal
  adhesion and ErbB pathways.
reftext: Faisal Alowaidi, et al. Oncol Lett. 2019 Sep;18(3):3399-3406.
pmc_ranked_result_index: '29161'
pathway_score: 0.8546834
filename: ol-18-03-3399-g01.jpg
figtitle: Putative Cripto-1 targets the MAPK, FA and ErbB signalling pathways
year: '2019'
organisms: Homo sapiens
ndex: 0d7e096c-df21-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6676405__ol-18-03-3399-g01.html
  '@type': Dataset
  description: Putative Cripto-1 targets the MAPK, FA and ErbB signalling pathways.
    Solid arrows and boxes represent the data observed in U87-Cr1 cells confirmed
    from the literature, while dotted arrows and boxes represent data based on Kyoto
    Encyclopedia of Genes and Genomes pathway analysis but it is not known if Cripto-1
    signals through these cascades or directly regulate these putative targets. Cripto-1
    phosphorylates EGFR (Ser1070) or FGFR1 (Tyr654) which may be a part of the MAPK
    signalling pathway mediating cellular proliferation. In the FA pathway, Cripto-1
    may regulate cell motility and invasion through binding ITGA, mediating the activation
    of the Src signalling cascade (Tyr418), FAK (Tyr396) and PXN (Tyr118). In addition,
    Cripto-1 may signal, through the same binding, to control cellular survival through
    Src (Tyr418), FAK (Tyr396), p130CAS (Tyr410) and Bcl2 (Thr69) or to regulate cellular
    proliferation through Src (Tyr418), FAK (Tyr396), p130CAS (Tyr410) c-Jun (Ser63).
    This representative figure shows that Cripto-1 may signal through the ErbB signalling
    pathway to control cell migration, invasion and adhesion or angiogenesis via the
    signalling cascade ErbB1 (EFGR)(Ser1070)/ErbB2 (Her2)(Tyr877), Src (Tyr418), and
    FAK (Tyr396) or ErbB1 (EFGR)(Ser1070)/ErbB2 (Her2)(Tyr877), c-Jun (Ser63), respectively.
    MAPK, mitogen-activated protein kinase; FA, focal adhesion; EGFR, epithelial growth
    factor receptor; FGFR, fibroblast growth factor receptor; ITGA, integrin a subunit;
    FAK, focal adhesion kinase; PXN, Paxillin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PXN
  - BCAR1
  - TERF2IP
  - SRC
  - NCK1
  - PAK5
  - BCL2
  - BRAF
  - JUN
  - TDGF1
  - CRK
  - CCND1
  - CCND2
  - CCND3
  - EGFR
  - PAK2
  - PAK3
  - PAK6
  - ACTG2
  - ERBB2
  - MAPK1
  - MAPK3
  - PTK2
  - FGFR1
  - RASGRF2
  - MAPK8
  - MAPK9
  - PAK1
  - PAK4
  - ACTG1
  - MAPK11
  - MAPK10
  - MAPK13
  - MAPK12
  - MAP2K1
  - MAP2K2
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ERBB3
  - ERBB4
  - MAPK14
  - Ser1070
  - Tyr877
  - Ser
  - Thr
  - Cancer
genes:
- word: PXN
  symbol: PXN
  source: hgnc_symbol
  hgnc_symbol: PXN
  entrez: '5829'
- word: P130CAS
  symbol: P130Cas
  source: hgnc_alias_symbol
  hgnc_symbol: BCAR1
  entrez: '9564'
- word: RAP1
  symbol: RAP1
  source: hgnc_alias_symbol
  hgnc_symbol: TERF2IP
  entrez: '54386'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: Nck
  symbol: NCK
  source: hgnc_prev_symbol
  hgnc_symbol: NCK1
  entrez: '4690'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK5
  entrez: '57144'
- word: BCL2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: B-RAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: c-Jun
  symbol: c-Jun
  source: hgnc_alias_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: Cripto-1
  symbol: Cripto-1
  source: hgnc_alias_symbol
  hgnc_symbol: TDGF1
  entrez: '6997'
- word: Crk
  symbol: CRK
  source: hgnc_symbol
  hgnc_symbol: CRK
  entrez: '1398'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK2
  entrez: '5062'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK3
  entrez: '5063'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK6
  entrez: '56924'
- word: ACTIN
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG2
  entrez: '72'
- word: ErbB2
  symbol: ERBB2
  source: hgnc_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: FGFR1
  symbol: FGFR1
  source: hgnc_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: Grf2
  symbol: GRF2
  source: hgnc_alias_symbol
  hgnc_symbol: RASGRF2
  entrez: '5924'
- word: (HER2)
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK1
  entrez: '5058'
- word: PAK
  symbol: PAK
  source: bioentities_symbol
  hgnc_symbol: PAK4
  entrez: '10298'
- word: ACTIN
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTG1
  entrez: '71'
- word: ErbB1&
  symbol: ERBB1
  source: hgnc_alias_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ACTIN
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA1
  entrez: '58'
- word: ACTIN
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTA2
  entrez: '59'
- word: ACTIN
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTB
  entrez: '60'
- word: ACTIN
  symbol: Actin
  source: bioentities_symbol
  hgnc_symbol: ACTC1
  entrez: '70'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: ErbB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
chemicals:
- word: Ser1070
  source: MESH
  identifier: C530429
- word: Tyr877
  source: MESH
  identifier: C049347
- word: Ser
  source: MESH
  identifier: C530429
- word: Thr
  source: MESH
  identifier: C055175
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6676405__F2
redirect_from: /figures/PMC6676405__F2
figtype: Figure
---
